The study, published in the journal Molecular Metabolism, has involved the participation of IDIBAPS researchers.
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
The Hospital Clínic and Leitat inaugurate the CATI Incubator, its incubator for Digital Health projects
The selected projects will focus on the development of new technologies to address unmet needs in Spanish and European health systems CATI Incubator...
Interview with Dr. Luisa Lázaro, Head of the Child and Youth Psychiatry and Psychology Service. We speak to her about how the restrictions derived from...
A team of physicians and researchers from UPF and from the hospitals Santa Creu i Sant Pau and Clínic de Barcelona, shows that the use of this innovative...
How does real-world handling affect protein drugs? Hospital Clínic researchers participate in the International RealHOPE project, funded by the IMI (Innovative Medicines Initiative) and EFPIA.
The goal of the project is to find out the critical factors that destabilise protein drugs during their handling at hospitals and patients’ homes.
Access to diagnostics could reduce the number of premature deaths in low-income and middle-income countries by 1.1 million
An analysis in which the Hospital Clínic participated as the only Spanish hospital, explores the accessibility of diagnostic methods in low- and middle-income...
Determinants associated with a severe form of COVID-19 in people living with HIV in Catalonia identified
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COVID-19...
Long COVID involves significant limitations in terms of quality of life, including among young people. One of the sequelae that has the greatest impact...
Researchers from the IIBB-CSIC-IDIBAPS participate in a study that shows the interaction of the receptor for cannabinoids with the BiP protein in terminals of inhibitory neurons, modulating anxiety
The findings open a new conceptual framework to understand the striking context-dependent pharmacological actions of cannabis in the brain.